Antibody Citations
OriGene products have been used extensively by scientists worldwide to improve their research efficiency. For your reference, we have collected a representation of citations for selected OriGene products and posted them at this site.
Search citations by gene symbols or target names
Here are some of the recent papers making use of OriGene products by fellow researchers.
| Target | Research Paper | Journal | Product | SKU |
|---|---|---|---|---|
| DSP | A Scandinavian case of skin fragility, alopecia and cardiomyopathy caused by DSP mutations. | Clinical and experimental dermatology, 2014 Sep | Antibody | AM09122SU-N |
| DSP | A Scandinavian case of skin fragility, alopecia and cardiomyopathy caused by DSP mutations. | Clinical and experimental dermatology, 2014 Sep | Antibody | BM5017 |
| DSP | The novel desmin mutant p.A120D impairs filament formation, prevents intercalated disk localization, and causes sudden cardiac death | Circ Cardiovasc Genet, 2013 Nov | Antibody | AM09122SU-N |
| DsRed-Monomer | Notch signaling determines cell-fate specification of the two main types of vomeronasal neurons of rodents | Development (Cambridge, England), 2022 Jul | Antibody | TA180084 |
| DsRed-Monomer | Livin modulates the apoptotic effects of vesicular stomatotitis virus in lung adenocarcinoma. | International journal of oncology, 2016 Aug | Antibody | TA183016 |
| DsRed2 | Geometric Constraints Regulate Energy Metabolism and Cellular Contractility in Vascular Smooth Muscle Cells by Coordinating Mitochondrial DNA Methylation | Advanced Science, 2022 Sep | Antibody | TA183002 |
| DsRed2 | Nuclear interaction of Arp2/3 complex and BRAF V600E promotes aggressive behavior and vemurafenib resistance of thyroid cancer | American Journal of Cancer Research, 2022 Jul | Antibody | TA183025 |
| DSRED2 | Glucose restriction drives spatial reorganization of mevalonate metabolism | eLife, 2021 Apr | Antibody | TA180005 |
| DSTN | New Insights into the Disease Progression Control Mechanisms by Comparing Long-Term-Nonprogressors versus Normal-Progressors among HIV-1-Positive Patients Using an Ion Current-Based MS1 Proteomic Profiling | Journal of proteome research, 2015 Dec | Antibody | TA502654 |
| DUOX2 | DUOX2 promotes the progression of colorectal cancer cells by regulating the AKT pathway and interacting with RPL3 | Carcinogenesis, 2020 Jun | Antibody | TA309632 |
| DUSP1 | MicroRNA-760-mediated low expression of DUSP1 impedes the protective effect of NaHS on myocardial ischemia-reperfusion injury | Biochem. Cell Biol., 2020 Mar | Antibody | TA890036 |
| DUSP1 | Prolonged Pro-Inflammatory Cytokine Production in Monocytes Following Influenza Vaccination is Modulated by IL-10 in Older Adults | J. Infect. Dis., 2014 Nov | Antibody | TA325421 |
| DVL1 | Secreted phosphoprotein-1 accelerates the progression of human colorectal cancer through activating β-catenin signaling | Oncology letters, 2021 May | Antibody | TA329899 |
| DYSF | Unmasking potential intracellular roles for dysferlin through improved immunolabeling methods | J. Histochem. Cytochem., 2011 Nov | Antibody | AP07909PU-N |
| Dystrophin | Diagnostic significance of CK19, galectin-3, CD56, TPO and Ki67 expression and BRAF mutation in papillary thyroid carcinoma | Oncology Letters, 2018 Apr | Antibody | TA353791 |
| E Cadherin | Cathepsin B defines leader cells during the collective invasion of salivary adenoid cystic carcinoma | Int J Oncol, 2019 Feb | Antibody | UM870076 |
| E Cadherin | Macrophages significantly enhance wound healing in a vascularized skin model | J Biomed Mater Res A, 2019 Feb | Antibody | UM870076 |
| E Cadherin | Telocinobufagin inhibits the epithelial-mesenchymal transition of breast cancer cells through the phosphoinositide 3-kinase/protein kinase B/extracellular signal-regulated kinase/Snail signaling pathway | Oncol Lett, 2018 May | Antibody | UM870076 |
| E1 | Enhancing Hepatitis C virus pseudoparticles infectivity through p7NS2 cellular expression. | Journal of virological methods, 2020 May | Antibody | BM3324 |
| E1 | Pseudotyping retrovirus like particles vaccine candidates with Hepatitis C virus envelope protein E2 requires the cellular expression of CD81 | AMB Express, 2019 Feb | Antibody | BM3324 |
| E1 | Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression | Viruses, 2018 Aug | Antibody | BM3324 |
| E1 | High-yield production of a chimeric glycoprotein based on permuted E1 and E2 HCV envelope ectodomains | J. Virol. Methods, 2017 Dec | Antibody | BM3324 |
| E1 | High, Broad, Polyfunctional, and Durable T Cell Immune Responses Induced in Mice by a Novel Hepatitis C Virus (HCV) Vaccine Candidate (MVA-HCV) Based on Modified Vaccinia Virus Ankara Expressing the Nearly Full-Length HCV Genome | Journal of Virology, 2013 Jul | Antibody | BM3324 |
| E2 | Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot | PLoS ONE, 2018 Jan | Antibody | AP00757PU-N |
| E2-CRIMSON | PML-Nuclear Bodies Regulate the Stability of the Fusion Protein Dendra2-Nrf2 in the Nucleus | Cell. Physiol. Biochem., 2018 May | Antibody | TA183017 |
| E2F1 | Panobinostat sensitizes cyclin E high, homologous recombination-proficient ovarian cancer to olaparib | Gynecologic oncology, 2017 Oct | Antibody | TA308764 |
| E2F1 | E2F1 interactions with hHR23A inhibit its degradation and promote DNA repair | Oncotarget, 2016 May | Antibody | TA308764 |
| Early Nuclear Antigen | Rare detection of cytomegalovirus in severe fetal malformations in China. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2017 Nov | Antibody | BM3227 |
| EBF1 | Dysregulation of a long noncoding RNA reduces leptin leading to a leptin-responsive form of obesity | Nat. Med., 2019 Mar | Antibody | TA305686 |
| EBNA3A | Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth | J. Virol., 2018 Oct | Antibody | AP05013PU-N |
| EBNA3A | Virus and cell RNAs expressed during Epstein-Barr virus replication | J. Virol., 2018 Mar | Antibody | AP05013PU-N |
| EBNA3A | EBNA3C coactivation with EBNA2 requires a SUMO homology domain | J. Virol., 2018 Jan | Antibody | AP05013PU-N |
| EBNA3A | Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma | Oncogene, 2016 Jul | Antibody | AP05013PU-N |
| EBNA3A | Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter | J. Virol., 2006 Sep | Antibody | AP05013PU-N |
| EBNA3A | Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model | J Virol., 2005 Nov | Antibody | AP05013PU-N |
| EBNA3A | Epstein-Barr virus can inhibit genotoxin-induced G1 arrest downstream of p53 by preventing the inactivation of CDK2 | Oncogene, 2003 Oct | Antibody | AP05013PU-N |
| EBNA3B | Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth | J. Virol., 2018 Oct | Antibody | AP05014PU-N |
| EBNA3B | Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus | J. Virol., 2018 Jul | Antibody | AP05014PU-N |
| EBNA3B | Virus and cell RNAs expressed during Epstein-Barr virus replication | J. Virol., 2018 Mar | Antibody | AP05014PU-N |
| EBNA3B | EBNA3C coactivation with EBNA2 requires a SUMO homology domain | J. Virol., 2018 Jan | Antibody | AP05014PU-N |
| EBNA3B | Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma | Oncogene, 2016 Jul | Antibody | AP05014PU-N |
| EBNA3B | Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter | J. Virol., 2006 Sep | Antibody | AP05014PU-N |
| EBNA3B | Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model | J Virol., 2005 Nov | Antibody | AP05014PU-N |
| EBNA3B | Epstein-Barr virus can inhibit genotoxin-induced G1 arrest downstream of p53 by preventing the inactivation of CDK2 | Oncogene, 2003 Oct | Antibody | AP05014PU-N |
| EBNA3C | Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth | J. Virol., 2018 Oct | Antibody | AP05015PU-N |
| EBNA3C | Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus | J. Virol., 2018 Jul | Antibody | AP05015PU-N |
| EBNA3C | Virus and cell RNAs expressed during Epstein-Barr virus replication | J. Virol., 2018 Mar | Antibody | AP05015PU-N |
| EBNA3C | EBNA3C coactivation with EBNA2 requires a SUMO homology domain | J. Virol., 2018 Jan | Antibody | AP05015PU-N |
| EBNA3C | Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma | Oncogene, 2016 Jul | Antibody | AP05015PU-N |
| EBNA3C | Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter | J. Virol., 2006 Sep | Antibody | AP05015PU-N |
Germany
Japan
United Kingdom
China